Physician profile
Michael D Halperin
NPI 1932145018
$1,599.79
in general payments reported to CMS, 2019-2025
10 companies · $279 in 2025
The $279 reported for 2025 was more than what 86% of Anesthesiology providers received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $153 · 2020: $190 · 2021: $65.96 · 2022: $250 · 2023: $337 · 2024: $325 · 2025: $279.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $941.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $940.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Neurocrine Biosciences, INC. | $605.59 | 2022-2025 | Ingrezza |
| Otsuka America Pharmaceutical, INC. | $321.37 | 2019-2025 | Rexulti |
| Scilex Pharmaceuticals INC. | $160.42 | 2021-2024 | Ztlido |
| Boston Scientific Corporation | $148.07 | 2024 | Wavewriter Alpha Prime 16 |
| Medtronic, INC. | $96.61 | 2023 | Intellis Adaptivestim |
| Stimwave Technologies Incorporated | $92.50 | 2020 | |
| Spr Therapeutics, INC | $80.81 | 2024 | Sprint Pns System |
| Grt US Holding, INC. | $60.00 | 2022 | |
| Lundbeck LLC | $26.08 | 2025 | Rexulti |
| Electronic Waveform Lab, INC. | $8.34 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Halperin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.